CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression [ 2013 - ]

Research Grant

Researchers: Prof David Johnson (Principal investigator) ,  A/Pr Gopala Rangan ,  A/Pr John Kanellis ,  A/Pr Sunil Badve ,  Dr Fiona Brown
View all 10 related researchers

Brief description Chronic kidney disease (CKD) is a major public health problem affecting over 1.5 million Australians and is associated with increased risk of death, heart disease and progression to end-stage kidney disease (ESKD). Current treatments to slow progression to ESKD are limited. The CKD-FIX trial aims to find out whether treatment with allopurinol, a commonly used drug for gout prevention, safely and effectively slows CKD progression. This could lead to significant health and economic benefits.

Funding Amount $1,917,147.00

Funding Scheme Project Grants

Notes Standard Project Grant